These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9822689)

  • 21. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
    Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
    J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solution structure of the human Hck SH3 domain and identification of its ligand binding site.
    Horita DA; Baldisseri DM; Zhang W; Altieri AS; Smithgall TE; Gmeiner WH; Byrd RA
    J Mol Biol; 1998 Apr; 278(1):253-65. PubMed ID: 9571048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
    Hiipakka M; Poikonen K; Saksela K
    J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1.
    Briggs SD; Sharkey M; Stevenson M; Smithgall TE
    J Biol Chem; 1997 Jul; 272(29):17899-902. PubMed ID: 9218412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of src-like kinases to the beta-subunit of the interleukin-3 receptor.
    Burton EA; Hunter S; Wu SC; Anderson SM
    J Biol Chem; 1997 Jun; 272(26):16189-95. PubMed ID: 9195918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase.
    Sotirellis N; Johnson TM; Hibbs ML; Stanley IJ; Stanley E; Dunn AR; Cheng HC
    J Biol Chem; 1995 Dec; 270(50):29773-80. PubMed ID: 8530369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein.
    Lee CH; Leung B; Lemmon MA; Zheng J; Cowburn D; Kuriyan J; Saksela K
    EMBO J; 1995 Oct; 14(20):5006-15. PubMed ID: 7588629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
    Kim HIe; Lee ST
    J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SH2-catalytic domain linker heterogeneity influences allosteric coupling across the SFK family.
    Register AC; Leonard SE; Maly DJ
    Biochemistry; 2014 Nov; 53(44):6910-23. PubMed ID: 25302671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment.
    Alvarado JJ; Tarafdar S; Yeh JI; Smithgall TE
    J Biol Chem; 2014 Oct; 289(41):28539-53. PubMed ID: 25122770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
    Dutartre H; Harris M; Olive D; Collette Y
    Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1.
    Scott MP; Zappacosta F; Kim EY; Annan RS; Miller WT
    J Biol Chem; 2002 Aug; 277(31):28238-46. PubMed ID: 12029088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.
    Schindler T; Sicheri F; Pico A; Gazit A; Levitzki A; Kuriyan J
    Mol Cell; 1999 May; 3(5):639-48. PubMed ID: 10360180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced phosphorylation of Src family kinase substrates containing SH2 domain binding sites.
    Pellicena P; Stowell KR; Miller WT
    J Biol Chem; 1998 Jun; 273(25):15325-8. PubMed ID: 9624111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain.
    Gouri BS; Swarup G
    Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the catalytic activity of the Src family tyrosine kinase Hck by autophosphorylation at a novel site in the unique domain.
    Johnson TM; Williamson NA; Scholz G; Jaworowski A; Wettenhall RE; Dunn AR; Cheng HC
    J Biol Chem; 2000 Oct; 275(43):33353-64. PubMed ID: 10934191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Brk SH3 domain in substrate recognition.
    Qiu H; Miller WT
    Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.